packageVoxelotor

voxelotor

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Voxelotor is a hematological drug developed for the treatment of sickle cell anemia. Its marketing in the European Union has been suspended, so it is no longer available there.

Summary written by glm-5.3-flash from Wikidata Q60761545 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:voxelotor
ATC codes:B06AX03
DrugBank:DB14975
PubChem CID:71602803
Wikidata:Q60761545
formula:C19H19N3O3
molar mass:337.379 g/mol (PubChem CID 71602803)
logP:2.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown